Iimveliso ezifakwe kwi-CBD ziza kwiWalgreens kunye neCVS ekufutshane nawe

Umxholo

• Uphengululo lwe

I-CBD (i-cannabidiol) yenye yeendlela ezintsha zokuphila qete eziqhubeka nokukhula ekuthandeni. Ngaphezulu kokuchithwa njengonyango olunokubakho kulawulo lweentlungu, unxunguphalo, kunye nokunye, ikhompawundi ye-cannabis iye yenyuka kuyo yonke into ukusuka kwiwayini, ikofu, kunye nezithambiso, ukuya kwisini nakwimveliso yexesha. Kungenxa yoko le nto kungothusi ukuba iiCVS kunye neeWalgreens ziya kuqala ukuthengisa iimveliso ezifakwe yi-CBD kwiindawo ezikhethiweyo kulo nyaka.

Phakathi kwamatyathanga amabini, iivenkile ezingama-2,300 ziya kucoca iishelufu ukwazisa iikhrimu ezifakwe kwi-CBD, i-lotion, iipatches, kunye nezitshizi, kwilizwe lonke, ngokutsho Forbes. Okwangoku, ukumiliselwa kunqunyelwe kumazwe alithoba athe asemthethweni ukuthengisa intsangu, kubandakanya iColorado, Illinois, Indiana, Kentucky, New Mexico, Oregon, Tennessee, South Carolina, kunye neVermont.

Ukuba uyi-CBD rookie, yazi ukuba izinto azikuphakamisi. Ivela kwii-cannabinoids kwi-cannabis kwaye emva koko ixutywe neoyile yenethiwekhi, njenge-MCT (ifom yeoyile yekhokhonathi), kwaye ayinaziphumo zibi, ngokwe-World Health Organisation. I-CBD ide ibe yinkwenkwezi yegolide evela kwi-FDA xa kufikwa ekunyangeni ukubanjwa: NgoJanuwari ophelileyo, i-arhente ivume i-Epidiolex, isisombululo somlomo se-CBD, njengonyango lweendlela ezimbini ezinzima kakhulu zokuxhuzula. (Nantsi yonke into ekufuneka uyazi ngumahluko phakathi kwe-CBD, i-THC, i-cannabis, intsangu kunye ne-hemp.)

Okwangoku, iiWalgreens okanye iiCVS azabelananga ngokuchanekileyo ziimpawu ze-CBD abaza kuzongeza kulungelelwaniso lwabo. Kodwa inyani yokuba ezi mpawu zikazwelonke zibeka ubunzima bazo emva kwezi mveliso ziindaba ezimnandi kubathandi be-CBD kuyo yonke indawo-ingakumbi xa kuziwa ekuthengeni iimveliso onokuthi uzithembe.

Kuba i-CBD isentsha kwimakethi yezempilo, ayilawulwa yi-FDA. Ngamanye amazwi, i-arhente ayijongi ngokungqongqo ukuyilwa kunye nokuhanjiswa kwe-CBD, ke abavelisi abajongwanga ngokungqongqo xa kufikwa kwindlela abadibanisa ngayo, bayilebhile kwaye bayithengise njani indalo yabo ye-cannabis. Oku kunqongophala kommiselo kunokushiya ucango luvulekile kubathengisi abazama nje ukwenza imali ngezi mveliso zinefashoni ngokusebenzisa intengiso yobuxoki kunye/okanye ekhohlisayo.

Ngapha koko, uphononongo olwenziwe yi-FDA lufumanise ukuba malunga neepesenti ezingama-26 zeemveliso ze-CBD kwintengiso yazo ziqulathe i-CBD nge-millilitre encinci kunaleyo icetyiswayo. Kwaye ngaphandle kwemithetho encinci, kunzima kubathengi be-CBD ukuba bathembe okanye bazi ukuba bathenga ntoni ngokwenene.

Kodwa ngoku ukuba i-CVS kunye neWalgreens zenza iimveliso ze-CBD zifikeleleke ngakumbi, kunokubakho ukutyhala okukhulu kwisikhokelo esitsha solawulo. Isakhiwo esitsha esicocekileyo ngethemba siza kubonelela ngesikhokelo sekhonkrithi malunga nokuba zeziphi iimveliso ze-CBD ezinokuthi-kwaye ngokubaluleke ngakumbi-azinakukwenza ngaphambi kokubeka iimveliso zabo kwintengiso. Kwinyani, sisenendlela ende ekufuneka sihambe, kodwa ezi ndaba ngokuqinisekileyo zisisondeza inyathelo elinye ekwenzeni ukuthengwa kwe-CBD kukhuseleke kwaye kuthembeke kuwo wonke umntu.

Uphengululo lwe